MCID: HMN010
MIFTS: 59

Hemangioma malady

Categories: Genetic diseases (common), Cancer diseases

Aliases & Classifications for Hemangioma

About this section

Summaries for Hemangioma

About this section
Disease Ontology:11 A cell type benign neoplasm that has physical basis in endothelial cells that line blood vessels and is characterised by increased number of normal or abnormal vessels filled with blood.

MalaCards based summary: Hemangioma is related to cavernous hemangioma of face and meige syndrome. An important gene associated with Hemangioma is KDR (Kinase Insert Domain Receptor), and among its related pathways are Signaling events mediated by VEGFR1 and VEGFR2 and VEGF binds to VEGFR leading to receptor dimerization. The drugs interferon alfa-2b and recombinant interferon beta-1a have been mentioned in the context of this disorder. Affiliated tissues include endothelial, liver and lung, and related mouse phenotypes are digestive/alimentary and respiratory system.

Wikipedia:71 An infantile hemangioma (IH) is one of the most common benign tumors of infancy and occurs in... more...

Related Diseases for Hemangioma

About this section

Diseases in the Hemangioma family:

Acquired Hemangioma Hemangioma, Hereditary
Familial Hemangioma

Diseases related to Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 492)
idRelated DiseaseScoreTop Affiliating Genes
1cavernous hemangioma of face32.6CHGA, NKX2-1, SFTPB, SYP
2meige syndrome29.6CHGA, NKX2-1, SYP
3intrahepatic cholangiocarcinoma29.2LYVE1, PDPN, PROX1
4hemolytic anemia26.4ACTC1, ANGPT1, ANGPT2, CD34, CHGA, DIO3
5capillary hemangioma12.2
6cavernous hemangioma12.2
7non-involuting congenital hemangioma12.1
8hemangioma, capillary infantile12.1
9hemangioma-thrombocytopenia syndrome12.1
10sclerosing hemangioma12.1
11rapidly involuting congenital hemangioma12.0
12glomeruloid hemangioma12.0
13intramuscular hemangioma11.9
14pulmonary sclerosing hemangioma11.8
15giant hemangioma11.8
16spindle cell hemangioma11.8
17histiocytoid hemangioma11.8
18skin hemangioma11.8
19hemangioma of liver11.8
20venous hemangioma11.8
21hemangioma of spleen11.8
22hobnail hemangioma11.8
23gastric hemangioma11.8
24hemangioma of lung11.8
25acquired hemangioma11.8
26supraumbilical midabdominal raphe and facial cavernous hemangiomas11.8
27verrucous hemangioma11.8
28breast hemangioma11.8
29bone epithelioid hemangioma11.8
30diffuse cavernous hemangioma of the rectum11.7
31hemangioma of orbit11.7
32cavernous hemangioma of orbit11.7
33hemangioma, hereditary11.7
34intracranial structure hemangioma11.7
35hemangioma of intra-abdominal structure11.7
36central nervous system hemangioma11.7
37hemangioma of subcutaneous tissue11.7
38skin epithelioid hemangioma11.7
39cavernous hemangioma of colon11.7
40breast epithelioid hemangioma11.7
41hemangiomas, cavernous, of face and supraumbilical midline raphe11.6
42verrucous keratotic hemangioma11.6
43breast capillary hemangioma11.6
44sacral hemangiomas multiple congenital abnormalities11.6
45hemangioma, capillary infantile susceptibility11.6
46pyogenic granuloma11.6
47cerebral cavernous malformations-111.6
48angioma, hereditary neurocutaneous spinal arterial venous malformations with cutaneous hemangiomas, included11.6
49hemangioma of peripheral nerve11.6
50transverse limb deficiency hemangioma11.6

Graphical network of the top 20 diseases related to Hemangioma:



Diseases related to hemangioma

Symptoms & Phenotypes for Hemangioma

About this section

MGI Mouse Phenotypes related to Hemangioma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053819.5ANGPT2, FLT4, NKX2-1, PDPN, PECAM1, PROX1
2MP:00053889.2ANGPT2, KDR, NKX2-1, PDPN, PECAM1, PROX1
3MP:00053698.6ACTC1, ANGPT1, FGF2, FLT4, KDR, KRIT1
4MP:00053918.6ANGPT1, ANGPT2, FGF2, KDR, KRIT1, PROX1
5MP:00053787.7ACTC1, ANGPT1, CHGA, DIO3, FLT4, KDR
6MP:00053847.6ACTC1, ANGPT2, CD34, DIO3, FGF2, KDR
7MP:00053857.0ACTC1, ANGPT1, ANGPT2, CHGA, FGF2, FLT4
8MP:00107686.9ACTC1, ANGPT1, ANGPT2, CHGA, DIO3, FGF2
9MP:00053766.4ACTC1, ANGPT1, ANGPT2, CD34, CHGA, DIO3

Drugs & Therapeutics for Hemangioma

About this section

Drugs for Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 196)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Sufentanilapproved, investigationalPhase 418556030-54-741693
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
CID41693
Chronogesic
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
 
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
SUFENTANIL
Sufentanil
Sufentanil (USAN/INN)
Sufentanil Citrate
Sufentanil [USAN:BAN:INN]
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
2ParecoxibapprovedPhase 441198470-84-7
3
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
4
Propranololapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1228525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
5
Prednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
6
Dexmedetomidineapproved, vet_approvedPhase 459276631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
7
Ethiodized oilapprovedPhase 4968008-53-5
Synonyms:
 
EOE 13
8Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11573
9Autonomic AgentsPhase 4, Phase 3, Phase 210150
10Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 118340
11Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11193
12Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13093
13Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14207
14Adjuvants, AnesthesiaPhase 41674
15Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 223689
16Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15352
17NarcoticsPhase 43646
18Anesthetics, IntravenousPhase 42538
19AnestheticsPhase 49596
20Analgesics, OpioidPhase 43238
21AnalgesicsPhase 411733
22Analgesics, Non-NarcoticPhase 46501
23Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210729
24Anesthetics, GeneralPhase 42934
25Central Nervous System DepressantsPhase 413403
26Cyclooxygenase 2 InhibitorsPhase 4624
27Anti-Inflammatory Agents, Non-SteroidalPhase 44443
28Cyclooxygenase InhibitorsPhase 42870
29Antirheumatic AgentsPhase 410956
30Prednisolone acetatePhase 4, Phase 3, Phase 21193
31Prednisolone phosphatePhase 4, Phase 3, Phase 21193
32Prednisolone hemisuccinatePhase 4, Phase 3, Phase 21193
33Protective AgentsPhase 4, Phase 3, Phase 27443
34Adrenergic alpha-AgonistsPhase 41734
35Adrenergic AgonistsPhase 43027
36Vasodilator AgentsPhase 4, Phase 2, Phase 3, Phase 13543
37Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 213168
38AntiemeticsPhase 4, Phase 3, Phase 24022
39glucocorticoidsPhase 4, Phase 3, Phase 25103
40Gastrointestinal AgentsPhase 4, Phase 3, Phase 28402
41Hormone AntagonistsPhase 4, Phase 3, Phase 213180
42HormonesPhase 4, Phase 3, Phase 214415
43Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 21193
44Methylprednisolone acetatePhase 4, Phase 3, Phase 21193
45Neuroprotective AgentsPhase 4, Phase 3, Phase 21716
46Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25592
47Adrenergic alpha-2 Receptor AgonistsPhase 4980
48Hypnotics and SedativesPhase 42616
49
PseudoephedrineapprovedPhase 362890-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
50
TimololapprovedPhase 3, Phase 2, Phase 1, Early Phase 125226839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
 
NCGC00016038-02
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol anhydrous
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
timolol

Interventional clinical trials:

(show top 50)    (show all 181)
idNameStatusNCT IDPhase
1Role of Parecoxib Sodium for Postoperative Pain Management in Open HepatectomyUnknown statusNCT02204878Phase 4
2The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric HemangiomaCompletedNCT01908972Phase 4
3Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in NeurosurgeryRecruitingNCT02552459Phase 4
4Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety StudyActive, not recruitingNCT02378883Phase 4
5Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.Not yet recruitingNCT02625389Phase 4
6Postmarketing Safety Study of Hemoporfin in Patients With Port Wine StainNot yet recruitingNCT03181984Phase 4
7A Pilot Study of Hemoporfin PDT in Children With Port-wine StainNot yet recruitingNCT03125057Phase 4
8Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil SystemNot yet recruitingNCT02079818Phase 4
9Topical Timolol for Superficial Infantile HemangiomaUnknown statusNCT01685398Phase 3
10Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol GelUnknown statusNCT01272609Phase 3
11Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation SurgeryUnknown statusNCT01758211Phase 3
12Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2, Phase 3
13Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of InfancyCompletedNCT00312520Phase 3
14Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)CompletedNCT00267033Phase 3
15A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous MalformationCompletedNCT01677624Phase 3
16A Randomized Trial of Unruptured Brain AVMsCompletedNCT00389181Phase 3
17Nadolol Versus Propranolol in Children With Infantile HemangiomasRecruitingNCT02505971Phase 3
18CyberKnife Based Hypofractionated Radiotherapy for Vertebral HemangiomasRecruitingNCT02332408Phase 3
19Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile HemangiomaRecruitingNCT02342275Phase 3
20Trial of Sirolimus for Cognitive Impairment in Sturge-Weber SyndromeRecruitingNCT03047980Phase 2, Phase 3
21MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma PatientsNot yet recruitingNCT02962947Phase 2, Phase 3
22Propranolol in Capillary HemangiomasTerminatedNCT00744185Phase 2, Phase 3
23Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile HemangiomaTerminatedNCT01743885Phase 3
24Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot StudyUnknown statusNCT02317679Phase 2
25Nadolol for Proliferating Infantile HemangiomasCompletedNCT01010308Phase 2
26A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 2
27Topical Timolol Gel for the Treatment of Infantile HemangiomasCompletedNCT02145884Phase 2
28Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboCompletedNCT01512173Phase 2
29Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile HemangiomaCompletedNCT01072045Phase 2
30Measurement Skin Temperature During Pulsed Laser ExposureCompletedNCT00540917Phase 2
31The Effects of Aldara as an Adjunct to Laser TreatmentCompletedNCT00979550Phase 2
32Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)CompletedNCT00857662Phase 2
33Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
34Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2
35Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
36Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromeCompletedNCT02080624Phase 2
37Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1, Phase 2
38Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)RecruitingNCT02913612Phase 2
39Topical Timolol for Infantile Hemangioma in Early Proliferative PhaseRecruitingNCT02731287Phase 2
40A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsRecruitingNCT02110069Phase 2
41A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabRecruitingNCT02859441Phase 1, Phase 2
42Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)RecruitingNCT02484716Phase 2
43Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous MalformationsRecruitingNCT02042326Phase 2
44Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by SurgeryRecruitingNCT03148275Phase 2
45Proton Radiotherapy for Primary Central Nervous System Tumours in AdultsRecruitingNCT02797366Phase 2
46Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue SarcomaRecruitingNCT01532687Phase 2
47Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent GlioblastomaActive, not recruitingNCT03033524Phase 2
48Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
49Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeActive, not recruitingNCT02332655Phase 1, Phase 2
50Propranolol for Prevention of Threshold Retinopathy of PrematurityNot yet recruitingNCT03083431Phase 2

Search NIH Clinical Center for Hemangioma

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: hemangioma

Genetic Tests for Hemangioma

About this section

Genetic tests related to Hemangioma:

id Genetic test Affiliating Genes
1 Hemangioma27

Anatomical Context for Hemangioma

About this section

MalaCards organs/tissues related to Hemangioma:

36
Endothelial, Liver, Lung, Bone, Skin, Breast, Thyroid

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Hemangioma:
id TissueAnatomical CompartmentCell Relevance
1 HeartCardinal VeinsVenous Endothelial Cells Affected by disease

Publications for Hemangioma

About this section

Articles related to Hemangioma:

(show top 50)    (show all 2382)
idTitleAuthorsYear
1
Growing skull hemangioma: first and unique description in a patient with Klippel-TrAcnaunay-Weber syndrome. (27822901)
2017
2
Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report. (28056491)
2017
3
Segmental hemangioma of the head and neck: High prevalence of PHACE syndrome. (28089002)
2017
4
Rapamycin inhibits the proliferation of endothelial cells in hemangioma by blocking the mTOR-FABP4 pathway. (27914823)
2017
5
A case of diffuse cavernous hemangioma of the appendix: laparoscopic surgery can facilitate diagnosis and treatment. (28054281)
2017
6
Anastomosing Hemangioma of the Ovary: A Clinicopathological Study of Six Cases with Stromal Luteinization. (28050796)
2017
7
Mixed Hemangioma of the Nasal Cavity Destructing the Nasal Bone. (28060104)
2017
8
The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma. (28197761)
2017
9
Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment. (27981617)
2017
10
A Case of Giant Intradural Extramedullary Capillary Hemangioma. (28091424)
2017
11
Acquired hemangioma with features of Dabska tum or: an additional case. (27804154)
2017
12
Tricuspid Valve Hemangioma Associated with Hypoplastic Left Heart Syndrome Presenting as Sudden Infant Death Syndrome. (28272668)
2017
13
Ultrasound Diagnosis of Scrotal Wall Cavernous Hemangioma. (27981934)
2016
14
History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. (27610342)
2016
15
Sclerosing hemangioma: A diagnostic dilemma in fine needle aspiration cytology. (27168758)
2016
16
Inheritance Patterns of Infantile Hemangioma. (27940781)
2016
17
Transcervical excision of intramasseteric cavernous hemangioma: A case report. (26998058)
2016
18
Intracranial Capillary Hemangioma in the Posterior Fossa of an Adult Male. (27747124)
2016
19
Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma. (27231179)
2016
20
Juvenile capillary hemangioma. (27057499)
2016
21
Postictal Prosopometamorphopsia after Focal Status Epilepticus due to Cavernous Hemangioma in the Right Occipital Lobe. (27095527)
2016
22
Capillary hemangioma or pyogenic granuloma. (27041829)
2016
23
Cavernous Hemangioma of the Rib: A Case Report. (27878064)
2016
24
Cavernous hemangioma in unusual location: pterygopalatine fossa. (27117893)
2016
25
A case of giant fetal intracranial capillary hemangioma cured with propranolol. (26824594)
2016
26
Ectopic ACTH syndrome caused by pulmonary carcinoid tumor mimicking long-standing sclerosing hemangioma. (26828249)
2016
27
Intradural extramedullary capillary hemangioma: A case report and review of the literature. (27073572)
2016
28
Pleural effusion caused by a capillary hemangioma in the pleural cavity. (27087237)
2016
29
How to manage testicular capillary haemangioma: Editorial Comment on: W. BiaA8ek, S. Rudzki, L. Wroniecki: Capillary hemangioma of the testis. A case report of a rare benign tumor. (27104008)
2016
30
Visual function alterations in cavernous hemangioma of the orbital apex after surgery. (27803876)
2016
31
Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). (27114263)
2016
32
EP10.01: Isolated fetal neck hemangioma mimicking thyroid. (27644985)
2016
33
Intramuscular Hemangioma of the Pronator Quadratus Muscle of Forearm. (27454644)
2016
34
Spectral-Domain Optical Coherence Tomography Findings in Cavernous Hemangioma of the Optic Disk. (27552290)
2016
35
Multiparametric sonographic imaging of a capillary hemangioma of the testis: appearances on gray-scale, color Doppler, contrast-enhanced ultrasound and strain elastography. (26941881)
2016
36
Intramuscular hemangioma of the arm: ultrasonography and pathology features. (27516028)
2016
37
Resection of Giant Hemangioma of the Tongue Utilizing a Miniature Tourniquet Technique. (27391511)
2016
38
Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma. (27110421)
2016
39
Epidural spinal cavernous hemangioma and hybrid vascular subtype. (27487399)
2016
40
Calvarial bone cavernous hemangioma with intradural invasion: An unusual aggressive course-Case report and literature review. (27061482)
2016
41
Glomeruloid hemangioma and POEMS syndrome. (27208909)
2016
42
Intracranial capillary hemangioma misdiagnosed as a meningioma. (27097011)
2016
43
A very rare cause of abdominal pain in a male adolescent: cavernous hemangioma. (27599403)
2016
44
Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma. (26896817)
2016
45
Prenatal diagnosis of thrombosed dural sinus malformation with periorbital hemangioma: a case report. (26603566)
2016
46
Dyschromatosis symmetrica hereditaria complicated by intracranial hemangiomas and Parry-Romberg syndrome. (27040761)
2016
47
Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. (27660822)
2016
48
Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. (27601661)
2016
49
Pure laparoscopic right hepatectomy for giant hemangioma using anterior approach. (27620909)
2016
50
Choroidal haemangioma and photodynamic therapy. Anatomical and functional response of patients with choroidal hemangioma treated with photodynamic therapy. (28017484)
2016

Variations for Hemangioma

About this section

Expression for genes affiliated with Hemangioma

About this section
Search GEO for disease gene expression data for Hemangioma.

Pathways for genes affiliated with Hemangioma

About this section

Pathways related to Hemangioma according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.9FLT4, KDR, VEGFA
2
Show member pathways
9.9FLT4, KDR, VEGFA
39.9KDR, SLC2A1, VEGFA
49.9FGF2, KDR, VEGFA
59.9FGF2, KDR, VEGFA
69.7ACTC1, FGF2, KDR
79.7ANGPT1, TEK, VEGFA
8
Show member pathways
9.7FGF2, FLT4, KDR, VEGFA
99.7FGF2, KDR, PROX1, VEGFA
109.6FGF2, SLC2A1, SYP, VEGFA
119.5ANGPT1, ANGPT2, SLC2A1, VEGFA
129.4ANGPT2, FGF2, FLT4, KDR, TEK
13
Show member pathways
9.3ANGPT1, ANGPT2, PECAM1, TEK
14
Show member pathways
9.3ANGPT1, FGF2, KDR, TEK, VEGFA
159.3ANGPT1, ANGPT2, SLC2A1, TEK, VEGFA
168.9ANGPT1, ANGPT2, FGF2, FLT4, KDR, TEK
17
Show member pathways
8.9ANGPT1, ANGPT2, FGF2, FLT4, KDR, SLC2A1
18
Show member pathways
8.9ANGPT2, FGF2, FLT4, KDR, PECAM1, PROX1
19
Show member pathways
8.7ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRIT1

GO Terms for genes affiliated with Hemangioma

About this section

Cellular components related to Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell peripheryGO:00719449.9CD34, LYVE1, PECAM1
2membrane raftGO:00451219.2ANGPT1, KDR, PECAM1, SLC2A1, TEK
3extracellular spaceGO:00056158.6ACTC1, ANGPT1, ANGPT2, CHGA, FGF2, KRIT1
4extracellular regionGO:00055768.5ANGPT1, ANGPT2, CD34, CHGA, FGF2, FLT4

Biological processes related to Hemangioma according to GeneCards Suite gene sharing:

(show all 38)
idNameGO IDScoreTop Affiliating Genes
1lymph vessel developmentGO:000194510.8FLT4, PROX1
2positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.8KDR, VEGFA
3positive regulation of positive chemotaxisGO:005092710.8KDR, VEGFA
4positive regulation of protein kinase C signalingGO:009003710.7FLT4, VEGFA
5negative regulation of blood vessel endothelial cell migrationGO:004353710.7ANGPT2, FGF2
6cellular response to vascular endothelial growth factor stimulusGO:003592410.7FLT4, KDR, VEGFA
7cell migration involved in sprouting angiogenesisGO:000204210.7FGF2, KDR, VEGFA
8endothelium developmentGO:000315810.6CD34, KDR
9positive regulation of cellular component movementGO:005127210.6PDPN, VEGFA
10positive regulation of focal adhesion assemblyGO:005189410.5KDR, TEK, VEGFA
11negative regulation of angiogenesisGO:001652510.5ANGPT2, KRIT1, TEK
12skeletal muscle thin filament assemblyGO:003024010.5ACTC1, PROX1
13glomerular endothelium developmentGO:007201110.5CD34, PECAM1
14positive chemotaxisGO:005091810.5ANGPT1, FGF2, VEGFA
15positive regulation of blood vessel endothelial cell migrationGO:004353610.5ANGPT1, FGF2, VEGFA
16positive regulation of vasculogenesisGO:200121410.4CD34, KDR
17lymphangiogenesisGO:000194610.4FLT4, PDPN, PROX1
18glomerulus vasculature developmentGO:007201210.4ANGPT1, ANGPT2, TEK
19peptidyl-tyrosine phosphorylationGO:001810810.4FGF2, FLT4, KDR, TEK
20stem cell proliferationGO:007208910.4CD34, FGF2
21positive regulation of phosphatidylinositol 3-kinase signalingGO:001406810.4ANGPT1, KDR, TEK
22sprouting angiogenesisGO:000204010.3ANGPT1, FLT4, TEK
23positive regulation of protein phosphorylationGO:000193410.3FLT4, KDR, TEK, VEGFA
24negative regulation of endothelial cell apoptotic processGO:200035210.3ANGPT1, KDR, KRIT1, TEK
25Tie signaling pathwayGO:004801410.2ANGPT1, ANGPT2, TEK
26lung developmentGO:003032410.2NKX2-1, PDPN, PROX1, VEGFA
27positive regulation of cell proliferationGO:000828410.2FGF2, FLT4, KDR, PROX1, VEGFA
28vascular endothelial growth factor signaling pathwayGO:003808410.1FLT4, KDR
29vascular endothelial growth factor receptor signaling pathwayGO:004801010.1FLT4, KDR, VEGFA
30transmembrane receptor protein tyrosine kinase signaling pathwayGO:000716910.1ANGPT1, FLT4, KDR, TEK
31positive regulation of ERK1 and ERK2 cascadeGO:007037410.0ANGPT1, FGF2, FLT4, KDR, TEK
32positive regulation of endothelial cell proliferationGO:00019389.9FGF2, FLT4, KDR, PROX1, TEK, VEGFA
33positive regulation of endothelial cell migrationGO:00105959.8ANGPT1, FLT4, KDR, PROX1, TEK, VEGFA
34negative regulation of apoptotic processGO:00430669.8ACTC1, ANGPT1, FLT4, KDR, TEK, VEGFA
35leukocyte migrationGO:00509009.7ANGPT1, ANGPT2, CD34, PECAM1, TEK
36positive regulation of angiogenesisGO:00457669.6ANGPT2, CD34, FGF2, KDR, TEK, VEGFA
37angiogenesisGO:00015259.5ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRIT1
38multicellular organism developmentGO:00072759.4ANGPT1, ANGPT2, FGF2, KDR, PDPN, PROX1

Molecular functions related to Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor bindingGO:001983810.5FLT4, KDR, TEK
2protein tyrosine kinase activityGO:000471310.1FGF2, FLT4, KDR, TEK
3vascular endothelial growth factor-activated receptor activityGO:000502110.1FLT4, KDR
4transmembrane receptor protein tyrosine kinase activityGO:000471410.1FLT4, KDR, TEK

Sources for Hemangioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet